Eaderm
1 known investors
EADERM develops pharmaceuticals and functional products based on protection and control technologies for skin and hair tissue stem cells. Its R&D targets novel treatments for alopecia, pressure ulcers, and rare intractable diseases such as premature aging syndromes.
Founders & leadership
TK
Takehiko KanekoPresident & Representative Director
Investors · 1
Frequently asked questions
- What does Eaderm do?
- EADERM develops pharmaceuticals and functional products based on protection and control technologies for skin and hair tissue stem cells. Its R&D targets novel treatments for alopecia, pressure ulcers, and rare intractable diseases such as premature aging syndromes.
- Who are Eaderm's investors?
- Eaderm's investors include UntroD Capital.